DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect of Actonel on Periodontal Health of Postmenopausal Women

Information source: University Hospital Case Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Periodontal Disease

Intervention: Risedronate (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: University Hospital Case Medical Center

Official(s) and/or principal investigator(s):
james liu, md, Principal Investigator, Affiliation: UHCMC
leena palomo, dds msd, Principal Investigator, Affiliation: uhcmc

Overall contact:
leena palomo, dds msd, Phone: 2163686300, Email: leena.palomo@case.edu

Summary

Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.

Clinical Details

Official title: Effect of Actonel on Periodontal Health of Postmenopausal Women

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Primary outcome: Periodontal alveolar bone changes

Secondary outcome: Periodontal attachment levels

Detailed description: Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.

Eligibility

Minimum age: 40 Years. Maximum age: 80 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Osteopenia

- Postmenopausal

Exclusion Criteria:

- Male

- Diabetes

Locations and Contacts

leena palomo, dds msd, Phone: 2163686300, Email: leena.palomo@case.edu

Uhcmc, Cleveland, Ohio 44124, United States; Recruiting
james liu, md, Principal Investigator
Additional Information

Starting date: January 2008
Last updated: February 25, 2009

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017